Prithviraj Bose, MD | Authors


A Study Exploring Sotatercept and Ruxolitinib in MPN-Associated Myelofibrosis and Anemia

January 17, 2018

Prithviraj Bose, MD, an associate professor in the Department of Leukemia, Division of Cancer Medicine, at The University of Texas MD Anderson Cancer Center, discusses a study exploring sotatercept (ACE-011) alone and in combination with ruxolitinib (Jakafi) in patients with myeloproliferative neoplasm (MPN)-associated myelofibrosis and anemia.